Tag - vaccinations



Take any scientific issue that involves political choices, from public health to climate change, all sides claim to be basing their concerns on science.
Jan 2, 2024
Let’s stop insulting each other as ‘anti-science’
Take any scientific issue that involves political choices, from public health to climate change, all sides claim to be basing their concerns in science.
Demonstrators rally against COVID-19 vaccine mandates in Buffalo, New York, in February 2022.
Dec 26, 2023
It’s past time scientists admitted their COVID-19 mistakes
In 2019, 13% of Americans were distrustful enough to say they weren’t confident in scientists to act in the public’s best interest. Now it is 27%.
Alex Zhavoronkov, founder and chairman of Insilico Medicine, poses at his research facility in Suzhou, China, on Oct. 31.
WORLD / Science & Health
Nov 14, 2023
Race for first drug discovered by AI nears key milestone
Insilico Medicine's AI-developed drug for idiopathic pulmonary fibrosis is in midstage trials in the U.S. and China.
A health care worker administers the COVID-19 vaccine to a child in Rio de Janeiro in January 2022.
Oct 30, 2023
How we got COVID’s risk right but the response wrong
It was not the initial consensus on the fatality rate that drove the response but rather the way the risks of COVID-19 were balanced with the costs.
Troy Sutton, a virologist at Pennsylvania State University, on July 25, 2023. Sutton says that health officials referred to the public controversy over the lab leak theory in advising him to pursue different experiments.
WORLD / Science & Health
Oct 18, 2023
Lab leak fight casts chill over virology research
While some believe practices such as gain-of-function research could fend off the next pandemic, others worry that they are more likely to start one.
When COVID-19 first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
BUSINESS / Companies
Oct 18, 2023
Life after COVID turns rocky for reshaped health care businesses
When the coronavirus first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
Employees monitor the production of Covishield, the local name for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, at the Serum Institute of India in Pune, Maharashtra, India.
BUSINESS / Companies
Oct 5, 2023
Top vaccine maker seeks growth by selling shots to globetrotters
Serum Institute of India plans to start production of yellow fever and dengue shots for travelers to countries where those diseases are endemic.
A new study defines some critical differences in certain biomarkers of people with long COVID.
Oct 4, 2023
Long COVID is real. Now the evidence is piling up.
In what the researchers believe is a first, they did a detailed study of the differences between people with long COVID and those who are healthy.
Katalin Kariko (right) and Drew Weissman, the winners of the 2023 Nobel Prize in physiology or medicine for their discoveries enabling the development of mRNA COVID-19 vaccines
Oct 3, 2023
Nobel for mRNA vaccines shows the power of perseverance
Decades of work by Nobel Prize winners Kariko and Weissman made the rapid development of COVID-19 mRNA vaccines possible.
A nurse prepares a malaria vaccine before administering it to an infant in Kisumu, Kenya, in July 2022.
WORLD / Science & Health
Oct 3, 2023
WHO recommends malaria vaccine that will be rolled out next year
R21/Matrix-M, developed by Britain's University of Oxford, will become available by mid-2024
A screen at the Karolinska Institute shows this year's laureates Katalin Kariko of Hungary (left) and Drew Weissman of the U.S. during the announcement of the winners of the Nobel Prize in physiology or medicine.
WORLD / Science & Health
Oct 2, 2023
Pair win medicine Nobel for work related to COVID-19 vaccines
Their findings "fundamentally changed our understanding of how mRNA interacts with our immune system," the Nobel committee said.
Preliminary data suggests that updated COVID-19 boosters, which are matched to a previous variant known as XBB, could still offer protection against the new edition.
Sep 7, 2023
New Pirola COVID-19 variant shows value of booster shots
Data suggests the updated COVID-19 boosters, which are matched to the XBB variant, could still offer decent protection against the new edition.
A vial of the Moderna COVID-19 booster vaccine targeting BA.4 and BA.5 omicron subvariants. Japan will roll out an updated version targeting the XBB variant on Wednesday.
JAPAN / Explainer
Sep 19, 2023
Japan to begin COVID vaccine drive targeting XBB subvariant
The free shots will be offered until March next year to prepare residents for an expected uptick in infections during the winter.
A man receives a COVID-19 vaccination  at Aoyama University in Tokyo in August 2021.
JAPAN / Science & Health
Sep 9, 2023
Japan to end free COVID-19 vaccinations in March
From fiscal 2024, the country will provide a COVID-19 shot once a year between to people aged 65 or over who are at high risk of severe symptoms.
One big challenge public health officials now face is how to restore trust so that people listen to future guidance on everything from flu shots to childhood vaccines.
Aug 27, 2023
Not all COVID-19 ‘misinformation’ is equal — nor misinformation
Public health scientists have to figure out how to get back to the kind of nuanced, thoughtful discussions that were the pre-pandemic norm.
Tourists walk along the road that leads to Kiyomizu Temple in Kyoto on Friday.
JAPAN / Science & Health
Aug 14, 2023
New coronavirus variant EG.5 gains momentum in Japan
The prevalence of EG.5, called Eris by health experts, nearly doubled in July to account for 22% of cases in Tokyo.
Whether it is a hot summer or a cold winter, humans spend 90% of their time inside and there is little evidence that seasonal changes affect COVID-19 transmission significantly. 
Aug 10, 2023
COVID-19’s summer resurgence resists easy answers
Be wary of anyone with a pat explanation for why COVID-19 waves rise and fall.
Japan Times
Jul 6, 2023
Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
Japan Times
Jun 27, 2023
COVAX vaccine initiative has $2.6 billion left to spend as pandemic recedes
The initiative is set to wind up at the end of this year, although some of its work will continue.
Japan Times
Jun 23, 2023
Eradicate breast cancer? The hunt for a vaccine looks promising
Women in the future may soon be able to get a series of shots that teach their immune systems how to quash breast cancer before it becomes a problem.


At the Akan International Crane Center, just north of the city of Kushiro proper, visitors can see the majestic red-crowned crane — a symbol of Hokkaido.
Faces of the north: A Hokkaido town grapples with depopulation